EdgarLookup

UNITED STATES ANTIMONY CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that UNITED STATES ANTIMONY CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-11.1%
Profit Margin
Net income ÷ revenue
-2.8%
Return on Assets
Net income ÷ assets
0.09x
Debt-to-Equity
Total liabilities ÷ equity
+162.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $39.26M Mar 19, 2026
FY2025 Dec 31, 2024 $14.94M Mar 19, 2026
FY2024 Dec 31, 2023 $8.69M Apr 18, 2025
FY2023 Dec 31, 2022 $11.04M Apr 12, 2024
FY2022 Dec 31, 2021 $7.75M Jul 18, 2023
FY2021 Dec 31, 2020 $5.24M Apr 4, 2022
FY2020 Dec 31, 2019 $8.27M Mar 31, 2021
FY2019 Dec 31, 2018 $9.03M Apr 14, 2020
FY2018 Dec 31, 2017 $10.23M Apr 1, 2019
FY2017 Dec 31, 2016 $11.89M Apr 2, 2018

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $39.26M Mar 19, 2026
FY2025 Dec 31, 2024 $14.94M Mar 19, 2026

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $10.23M Apr 2, 2018
FY2016 Dec 31, 2016 $11.89M Mar 31, 2017
FY2015 Dec 31, 2015 $13.11M Mar 30, 2016
FY2014 Dec 31, 2014 $10.77M Mar 16, 2015
FY2013 Dec 31, 2013 $11.02M Mar 17, 2014
FY2012 Dec 31, 2012 $12.04M Mar 18, 2013
FY2011 Dec 31, 2011 $13.12M Mar 14, 2012
FY2011 Dec 31, 2010 $9.07M Mar 14, 2012
FY2011 Dec 31, 2009 $4.10M Mar 14, 2012

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.87M Mar 19, 2026
FY2025 Dec 31, 2024 $3.47M Mar 19, 2026
FY2024 Dec 31, 2023 ($3.34M) Apr 18, 2025
FY2023 Dec 31, 2022 $2.00M Apr 12, 2024
FY2022 Dec 31, 2021 $838.6K Jul 18, 2023
FY2021 Dec 31, 2020 $205.7K Apr 4, 2022
FY2020 Dec 31, 2019 ($816.3K) Mar 31, 2021
FY2019 Dec 31, 2018 $1.5K Apr 14, 2020
FY2018 Dec 31, 2017 $275.5K Apr 1, 2019
FY2017 Dec 31, 2016 $536.7K Apr 2, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($4.34M) Mar 19, 2026
FY2025 Dec 31, 2024 ($1.73M) Mar 19, 2026
FY2024 Dec 31, 2023 ($6.35M) Apr 18, 2025
FY2023 Dec 31, 2022 $428.7K Apr 12, 2024
FY2022 Dec 31, 2021 ($60.5K) Jul 18, 2023
FY2021 Dec 31, 2020 ($3.29M) Apr 4, 2022
FY2020 Dec 31, 2019 ($3.67M) Mar 31, 2021
FY2019 Dec 31, 2018 $873.2K Apr 14, 2020
FY2018 Dec 31, 2017 ($1.13M) Apr 1, 2019
FY2017 Dec 31, 2016 ($1.31M) Apr 2, 2018

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($8.46M) Mar 19, 2026
FY2025 Dec 31, 2024 ($2.39M) Mar 19, 2026
FY2024 Dec 31, 2023 ($7.07M) Apr 18, 2025
FY2023 Dec 31, 2022 $348.2K Apr 12, 2024
FY2022 Dec 31, 2021 ($660.3K) Jul 18, 2023
FY2021 Dec 31, 2020 ($3.30M) Apr 4, 2022
FY2020 Dec 31, 2019 ($3.75M) Mar 31, 2021
FY2019 Dec 31, 2018 $547.0K Apr 14, 2020
FY2018 Dec 31, 2017 ($959.7K) Apr 1, 2019
FY2017 Dec 31, 2016 ($816.5K) Apr 2, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($9.69M) Mar 19, 2026
FY2025 Dec 31, 2024 $2.22M Mar 19, 2026
FY2024 Dec 31, 2023 ($4.75M) Apr 18, 2025
FY2023 Dec 31, 2022 ($249.3K) Apr 12, 2024
FY2022 Dec 31, 2021 ($2.43M) Jul 18, 2023
FY2021 Dec 31, 2020 ($1.31M) Apr 4, 2022
FY2020 Dec 31, 2019 ($11.4K) Mar 31, 2021
FY2019 Dec 31, 2018 ($656.6K) Apr 14, 2020
FY2018 Dec 31, 2017 $716.8K Apr 1, 2019
FY2017 Dec 31, 2016 $425.8K Apr 2, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $27.81M Mar 19, 2026
FY2025 Dec 31, 2024 $430.6K Mar 19, 2026
FY2024 Dec 31, 2023 $1.53M Apr 18, 2025
FY2023 Dec 31, 2022 $1.73M Apr 12, 2024
FY2022 Dec 31, 2021 $648.1K Jul 18, 2023
FY2021 Dec 31, 2020 $243.1K Apr 4, 2022
FY2020 Dec 31, 2019 $792.9K Mar 31, 2021
FY2019 Dec 31, 2018 $899.1K Apr 14, 2020
FY2018 Dec 31, 2017 $365.5K Apr 1, 2019
FY2017 Dec 31, 2016 $595.8K Apr 2, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $153.93M Mar 19, 2026
FY2025 Dec 31, 2024 $34.64M Mar 19, 2026
FY2024 Dec 31, 2023 $28.09M Apr 18, 2025
FY2023 Dec 31, 2022 $34.70M Apr 12, 2024
FY2022 Dec 31, 2021 $35.00M Jul 18, 2023
FY2021 Dec 31, 2020 $13.30M Apr 4, 2022
FY2020 Dec 31, 2019 $13.69M Mar 31, 2021
FY2019 Dec 31, 2018 $17.56M Apr 14, 2020
FY2018 Dec 31, 2017 $17.13M Apr 1, 2019
FY2017 Dec 31, 2016 $17.77M Apr 2, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.97M Mar 19, 2026
FY2025 Dec 31, 2024 $6.04M Mar 19, 2026
FY2024 Dec 31, 2023 $2.57M Apr 18, 2025
FY2023 Dec 31, 2022 $2.83M Apr 12, 2024
FY2022 Dec 31, 2021 $2.63M Jul 18, 2023
FY2021 Dec 31, 2020 $6.11M Apr 4, 2022
FY2020 Dec 31, 2019 $5.23M Mar 31, 2021
FY2019 Dec 31, 2018 $6.13M Apr 14, 2020
FY2018 Dec 31, 2017 $6.75M Apr 1, 2019
FY2017 Dec 31, 2016 $6.42M Apr 2, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $140.96M Mar 19, 2026
FY2025 Dec 31, 2024 $28.60M Mar 19, 2026
FY2025 Dec 31, 2023 $25.52M Mar 19, 2026
FY2024 Dec 31, 2022 $31.87M Apr 18, 2025
FY2023 Dec 31, 2021 $32.37M Apr 12, 2024
FY2022 Dec 31, 2020 $7.19M Jul 18, 2023
FY2021 Dec 31, 2019 $8.47M Apr 4, 2022
FY2020 Dec 31, 2018 $11.42M Mar 31, 2021
FY2019 Dec 31, 2017 $10.38M Apr 14, 2020
FY2018 Dec 31, 2016 $11.34M Apr 1, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($45.49M) Mar 19, 2026
FY2025 Dec 31, 2024 ($41.15M) Mar 19, 2026
FY2024 Dec 31, 2023 ($39.42M) Apr 18, 2025
FY2023 Dec 31, 2022 ($33.07M) Apr 12, 2024
FY2022 Dec 31, 2021 ($32.71M) Jul 18, 2023
FY2021 Dec 31, 2020 ($32.65M) Apr 4, 2022
FY2020 Dec 31, 2019 ($29.36M) Mar 31, 2021
FY2019 Dec 31, 2018 ($25.69M) Apr 14, 2020
FY2018 Dec 31, 2017 ($26.56M) Apr 1, 2019
FY2017 Dec 31, 2016 ($25.43M) Apr 2, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $30.49M Mar 19, 2026
FY2025 Dec 31, 2024 $18.17M Mar 19, 2026
FY2024 Dec 31, 2023 $11.90M Apr 18, 2025
FY2023 Dec 31, 2022 $19.06M Apr 12, 2024
FY2022 Dec 31, 2021 $21.36M Jul 18, 2023
FY2021 Dec 31, 2020 $665.1K Apr 4, 2022
FY2020 Dec 31, 2019 $115.5K Mar 31, 2021
FY2019 Dec 31, 2018 $56.7K Apr 14, 2020
FY2018 Dec 31, 2017 $28.0K Apr 1, 2019
FY2017 Dec 31, 2016 $10.1K Apr 2, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $195.4K Mar 19, 2026
FY2025 Dec 31, 2024 $327.7K Mar 19, 2026
FY2024 Dec 31, 2023 $0 Apr 18, 2025
FY2023 Dec 31, 2022 $217.9K Apr 12, 2024
FY2022 Dec 31, 2021 $201.9K Jul 18, 2023
FY2020 Dec 31, 2020 $86.4K Mar 31, 2021
FY2019 Dec 31, 2019 $133.1K Apr 14, 2020
FY2018 Dec 31, 2018 $1.73M Apr 1, 2019
FY2017 Dec 31, 2017 $1.79M Apr 2, 2018
FY2016 Dec 31, 2016 $1.86M Mar 31, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 19, 2026
FY2025 Dec 31, 2024 0 Mar 19, 2026
FY2024 Dec 31, 2023 0 Apr 18, 2025
FY2013 Dec 31, 2013 0 Mar 17, 2014
FY2013 Dec 31, 2012 0 Mar 17, 2014
FY2013 Dec 31, 2011 0 Mar 17, 2014
FY2011 Dec 31, 2010 0 Aug 22, 2013
FY2011 Dec 31, 2009 0 Aug 22, 2013

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 19, 2026
FY2025 Dec 31, 2024 0 Mar 19, 2026
FY2024 Dec 31, 2023 0 Apr 18, 2025
FY2013 Dec 31, 2013 0 Mar 17, 2014
FY2013 Dec 31, 2012 0 Mar 17, 2014
FY2013 Dec 31, 2011 0 Mar 17, 2014
FY2011 Dec 31, 2010 0 Aug 22, 2013
FY2011 Dec 31, 2009 0 Aug 22, 2013

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 140.04M Mar 19, 2026
FY2025 Dec 31, 2024 112.95M Mar 19, 2026
FY2024 Dec 31, 2023 107.65M Apr 18, 2025
FY2023 Dec 31, 2022 106.37M Apr 12, 2024
FY2022 Dec 31, 2021 106.24M Jul 18, 2023
FY2021 Dec 31, 2020 75.95M Apr 4, 2022
FY2020 Dec 31, 2019 69.66M Mar 31, 2021
FY2019 Dec 31, 2018 68.23M Apr 14, 2020
FY2018 Dec 31, 2017 67.49M Apr 1, 2019
FY2017 Dec 31, 2016 67.07M Apr 2, 2018